Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

GEMP

Gemphire Therapeutics (GEMP)

Gemphire Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GEMP
일자시간출처헤드라인심볼기업
2019/12/3120:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/3101:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/3101:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/3101:08GlobeNewswire Inc.Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
2019/12/0706:25Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/0706:24Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/0706:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/0706:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/12/0622:43GlobeNewswire Inc.Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
2019/11/0823:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
2019/11/0720:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
2019/11/0623:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
2019/11/0506:27Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/3019:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/3019:10Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/1119:02Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/0905:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/0905:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/0405:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/10/0405:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/09/2505:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/09/2505:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/09/0319:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/1521:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/1521:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/1406:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/1406:26Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/0921:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/0521:22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
2019/08/0306:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
 검색 관련기사 보기:NASDAQ:GEMP